Etentamig in previously treated WM

Recruiting
Written By Sustainable Digital

First trial using an anti-BCMA bispecific antibody for WM in the world

Sites: Mayo Clinic, Dana-Farber Cancer Institute, MD Anderson, Memorial Sloan Kettering Cancer Center, The Ohio State University Wexner Medical Center, University of Miami Health System

Accrual Status: protocol review

Sustainable Digital

Digital Communication services, including website design, search engine optimization, social media, and content creation for nonprofit organizations, consultants, and creative entrepreneurs.

http://www.sustainabledigital.com
Previous

Pirtobrutinib, Venetoclax, and Rituximab (PROVEN) in previously untreated WM